Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - Cellular Biomedicine Group, Inc. | cbmg_10k.htm |
| EX-32 - CERTIFICATION - Cellular Biomedicine Group, Inc. | cbmg_ex32.htm |
| EX-31 - CERTIFICATION - Cellular Biomedicine Group, Inc. | cbmg_ex31.htm |
| EX-23.1 - CONSENT - Cellular Biomedicine Group, Inc. | cbmg_ex231.htm |
| EX-23.2 - CONSENT - Cellular Biomedicine Group, Inc. | cbmg_ex232.htm |
| EX-10.39 - CONSULTING AGREEMENT - Cellular Biomedicine Group, Inc. | cbmg_ex1039.htm |
| EX-10.46 - CLINICAL TRIAL AGREEMENT - Cellular Biomedicine Group, Inc. | cbmg_ex1046.htm |
| EX-10.45 - PATENT TRANSFER AGREEMENT - Cellular Biomedicine Group, Inc. | cbmg_ex1045.htm |
| EX-10.43 - TECHNOLOGY TRANSFER CONTRACT - Cellular Biomedicine Group, Inc. | cbmg_ex1043.htm |
Exhibit 21
List of Subsidiaries of Cellular Biomedicine Group, Inc.:
|
Name
|
State of Incorporation/Formation
|
|
|
Cellular Biomedicine Group Ltd.
|
British Virgin Islands
|
|
|
Cellular Biomedicine Group Ltd.
|
Hong Kong
|
|
|
Cellular Biomedicine Group (Wuxi) Ltd.
|
People’s Republic of China
|
|
|
Cellular Biomedicine Group (Shanghai) Ltd.
|
People’s Republic of China (variable interest entity)
|
|
|
Beijing Agreen Biotechnology Co., Ltd.
|
People’s Republic of China (100% owned by Cellular Biomedicine Group (Shanghai) Ltd.)
|
|
|
Eastbridge Investment Corporation
|
Delaware
|
|
|
Cellular Biomedicine Group Vax, Inc.
|
California
|